Publications by Yuhei Kuriyama

Publications by authors named "Yuhei Kuriyama"

Am J Med

September 2024

Mod Rheumatol Case Rep

July 2021

*Recent studies have shown that tocilizumab (TCZ), particularly when administered subcutaneously (TCZ-SC), can be effective for treating ASD that does not respond to standard therapies.
*In a case series involving three patients, TCZ-SC led to rapid fever resolution and normalization of inflammatory markers without serious side effects, suggesting it could be a viable and cost-effective treatment option for refractory ASD.

- Yuhei Kuriyama's recent research encompasses clinical case studies focused on complex medical challenges, as illustrated by his article on tongue abscess leading to trismus in an older woman, published in the American Journal of Medicine in September 2024.
- His work also investigates the treatment of refractory adult Still's disease, showcasing the effectiveness of subcutaneous tocilizumab, with findings reported in a July 2021 article in Modern Rheumatology Case Reports.
- Kuriyama's research highlights the role of proinflammatory cytokines, particularly interleukin-6, in systemic inflammatory disorders, contributing to the understanding and management of challenging cases in rheumatology.